References
- 1. Alexiou A., Sourtzi P., Dimakopoulou K., Manolis E., Velonakis E. - Nasal polyps: heredity, allergies, and environmental and occupational exposure. J Otolaryngol Head Neck Surg., 2011;40:58-63.
- 2. Van Bruaene N., Perez Novo C., Deruyck N., Holtappels G., Van Cauwenberge P., Bachert C. - Inflammation and remodeling patterns in early-stage chronic rhinosinusitis. Clin Exp Allergy, 2012;42:883-890.
- 3. Van Bruaene N., Bachert C. - Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol., 2011;11:8-11.
- 4. Anand V.K. - Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol. Suppl., 2004;193:3-5.
- 5. Drake-Lee A. - The pathogenesis of nasal polyps. In: Settipane G.A., Lund V.J., Tos M. - Nasal polyps: epidemiology, pathogenesis and treatment. Providence, Rhode Island: Ocean Side Publications, 1997;p.57-64.
- 6. Kim J.W., Hong S.L., Kim Y.K., Lee C.H., Min Y.G., Rhee C.S. - Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg., 2007;137(6):925-930.
- 7. Simon H.U., Yousefi S., Schranz C., Schapowal A., Bachert C., Blaser K. - Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol., 1997;158(8):3902-3908.
- 8. Kim Y.M., Munoz A., Hwanq P.H., Nadeau K.C. - Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis. Clin Immunol., 2010;137(1):111-121. doi: 10.1016/j. clim.2010.05.013. Epub 2010 Jul 2.
- 9. Kato A., Schleimer R.P. - Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol., 2007;19(6):711-720.
- 10. Di Lorenzo G., Drago A., Esposito Pellitteri M., Candore G., Colombo A., Gervasi F., Pacor M.L., Purello D’Ambrosio F., Caruso C. - Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol., 2001;125(2):164-175.
- 11. Erbek S.S., Yurtcu E., Erbek S., Atac F.B., Sahin F.I., Cakmak O. - Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg., 2007;133(7):705-709.
- 12. Van Zele T., Claeys S., Gevaert P., Holtappels G., Van Cauwenberge P., Bachert C. - Differentiations of chronic sinus diseases by measurement of inflammatory mediators. Allergy, 2006;61(11):1280-1289.
- 13. Hamilos D.L., Leung D.Y.M., Wood R., Cunningham L., Bean D.K., Yasruel S., Schotman E., Hamid Q. - Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol., 1995;96:537-544.
- 14. Otto B.A., Wenzel S.E. - The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg., 2008;16(3):270-4. doi: 10.1097/ moo.0b013e3282fb2885.
- 15. Gevaert P., Lang-Loidolt D., Lackner A., Stammberger H., Staudinger H., Van Zele T., Holtappels G., Tavernier J., van Cauwenberge P., Bachert C. - Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol., 2006;118(5):1133-1141. Epub 2006 Sep 26.
- 16. de Borja Callejas F., Picado C., Martínez-Antón A., Alobid I., Pujols L., Valero A., Roca-Ferrer J., Mullol J. - Differential expression of remodeling markers by tissue structure in nasal polyposis. Am J Rhinol Allergy, 2013;27(3):e69-74. doi: 10.2500/ajra.2013.27.3908.
- 17. Hamilos D.L., Leung D.Y.M., Huston D.P., Kamil A., Wood R., Hamid Q. - GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy, 1998;28:1145-1152.
- 18. Perić A., Vijvodic D., Vukomanovic-Durdevic B., Baletic N. - Inflammatory mediators in allergic rhinitis and nasal polyposis. Arh Hig Rada Tokiskol., 2011;62(4):341-348. doi: 10.2478/10004-1254-62-2011-2120.
- 19. Hirschberg A., Jokuti A., Darvas Z., Almay K., Repassy G., Falus A. - The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Laryngoscope, 2003;113(1):120-124.
- 20. Gavaert P., Van Bruaene N., Cattaert T., Van Steen K., Van Zele T., Acke F., De Ruyck N., Blomme K., Sousa Ana R., Marshall Richard P., Bachert C. - Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. The Journal of Allergy and Clinical Immunology, 2011;128(5):989-995.e8.
- 21. Jankowski R., Moneret-Vautrin D.A., Goetz R., Wayoff M. - Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma. Rhinology, 1992;30(4):249-258.
- 22. Clutterbuck E.J., Hirst E.M., Sanderson C.J. - Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood, 1989;73(6):1504-1512.
- 23. Dellacono F.R., Eisma R., Lafreniere D., Leonard G., Kreutzer D. - Interferon gamma expression in human nasal polyps. Laryngoscope, 1997;107(5):626-630.
- 24. Mfuna Endam L., Cormier C., Bosse Y., Filali-Mouhim A., Desrosiers M. - Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study. Arch Otolaryngol Head Neck Surg., 2010;136:187-192. doi: 10.1001/archoto. 2009.219.
- 25. Kato A., Peters A., Suh L., Carter R., Harris K.E., Chandra R., Conley D., Grammer L.C., Kern R., Schleimer R.P. - Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol., 2008;121(6):1385-1392, 1392.e1-2. doi: 10.1016/jaci.2008.03.002. Epub 2008 Apr 14.
- 26. Saji F., Nonaka M., Pawankar R. - Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx, 2000;27:247-252.
- 27. Rosenberg H.F., Dyer K.D., Foster P.S. - Eosinophils: changing perspectives in health and disease. Nat Rev Immunol., 2013;13(1):9-22. doi: 10.1038/ hri3341. Epub 2012 Nov 16.
- 28. Gounni Abdelilah S., Wellemans V., Agouli M., Guenounou M., Hamid Q., Beck L.A., Lamkhioued B. - Increased expression of Th2-associated chemokines in bullous pemphigoid disease: Role of eosinophils in the production and release of these chemokines. Clin Immunol., 2006;120:220-231.
- 29. Liu L.Y., Bates M.E., Jarjour N.N., Busse W.W., Bertics P.J., Kelly E.A. - Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol., 2007;179(7):4840-4848.
- 30. Bachert C., Gevaert P., Holtappels G., Cuvelier C., van Cauwenberge P. - Nasal polyposis: from cytokines to growth. Am J Rhinol., 2000;14(5):279-290.
- 31. Patadia M., Dixon J., Conley D., Chandra R., Peters A., Suh L.A., Kato A., Carter R., Harris K., Grammer L., Kern R., Schleimer R. - Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy, 2010;24(1):11-6. doi: 10.2500/ajra.2010.24.3386.
- 32. Bartels J., Maune S., Meyer J.E., Kulke R., Schleter C., Rowert J., Christophers E., Schroeder J.M. - Increased eotaxin mRNA expression in non atopic and atopic nasal polyps: comparison to RANTES and MCP3 expression. Rhinology, 1997;35(4):171-174.
- 33. Yao T., Kojima Y., Koyanagi A., Yokoi H., Saito T., Kawano K., Furukawa M., Kusunoki T., Ikeda K. - Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope, 2009;119(6):1053-1059. doi: 10.1002/lary.20191.
- 34. Palframan R.T., Collins P.D., Williams T.J., Rankin S.M. - Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood, 1998;91(7):2240-2248.
- 35. Cavallari F.E., Valera F.C.P., Gallego A.J. et al. - Expression of RANTES, eotaxin-2, ICAM-1, LFA-1 and CCR-3 in chronic rhinosinusitis patients with nasal polyposis. Acta Cirurgica Brasileira, 2012;27(9):645-649.
- 36. Allen J.S., Eisma R., LaFreniere D., Leonard G., Kreutzer D. - Characterization of the eosinophil chemokine RANTES in nasal polyps. Ann Otol Rhinol Laryngol., 1998;107(5pt1):416-420.
- 37. Newton J.R., Ah-See K.W. - A review of nasal polyposis. Ther Clin Risk Manag., 2008;4(2):507-512.
- 38. Shin S.H., Park J.Y., Jeon C.H., Choi J.K., Lee S.H. - Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope, 2000;110(8):1353-1357.
- 39. Lane A.P., Truong-Tran Q.A., Schleimer R.P. - Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol., 2006;20(2):138-144.
- 40. Meyer J.E., Bartels J., Gorogh T., Sticherling M., Rudack C., Ross D.A., et al. - The role of RANTES in nasal polyposis. Am J Rhinol., 2005;19(1):15-20.
- 41. Ohkubo K., Masakazu I., Pawankar R., Gotoh M., Yagi T., Okuda M. - Mechanisms of IL-6, IL-8 and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology, 1998;36:156-161.
- 42. Allen J.S., Eisma R., Leonard G., Lafreniere D., Kreutzer D. - Interleukin-8 expression in human nasal polyps. Otolaryngol Head Neck Surg., 1997;117(5):535-541.
- 43. Corsi M.M., Pagani D., Dogliotti G., Perona F., Sambataro G., Pignataro L. - Protein biochip array of adhesion molecule expression in peripheral blood of patients with nasal polyposis. Int J Biol Markers., 2008;23(2):115-120.
- 44. Gonzalo J.A., Lloyd C.M., Kremer L., et al. - Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest., 1996;98(10):2332-2345.
- 45. Olejniczak I., Kobos J., Gryczyński M., Durko M., Pietruszewska W. - Expression of adhesion molecule ICAM-1 in patients with nasal polyps. Otolaryngol Pol., 2007;61(4):607-611. doi: 10.1016/S0030-6657(07)70495-X.
- 46. Sriramarao P., Broide D.H. - Differential regulation of eosinophil adhesion under conditions of flow in vivo. Ann NY Acad Sci., 1996;796:218-225.
- 47. Eweiss A., Dogheim Y., Hassab M., Tayel H., Hammad Z. - VCAM-1 and eosinophilia in diffuse sino-nasal polyps. Eur Arch Otorhinolaryngol., 2009;266:377-383. doi: 10.1007/s00405-008-0762-1.
- 48. Gosset P., Tillie-Leblond I., Janin A., Marguette C.H., Copin M.C., Wallaert B., Tonnel A.B. -Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol., 1995;106(1):69-77.
- 49. Papon J.F., Coste A., Gendron M.C., Cordonnier C., Wingerstmann L., Peynegre R., Escudier E. - HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope, 2002;112(11):2067-2075.
- 50. Symon F.A., Walsh G.M., Watson S.R., Wardlaw A.J. - Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med., 1994;180(1):371-376.